Elloria Medical Technologies

Company Overview

Snapshot

Founded in January 2010 by Arnon Epstein, Elloria Medical Technologies operates with 1–10 employees. The company has raised $1.2 million across one disclosed funding round and holds one patent. Elloria Medical Technologies is focused on developing advanced technologies for aesthetic and medical applications.

Business overview

Elloria Medical Technologies specializes in developing innovative technologies for aesthetic and medical applications and devices within the Health Tech & Life Sciences sector. Its core product, Electro Chemical Hair Obliteration (ECHO), is a permanent hair-removal system based on the patented Ellorion technology. This technology combines the efficacy of electrology with the ease-of-use and speed of light-based hair-removal systems, serving clinics and individual consumers in the dermatology market.

Company Intelligence Q&A

What is Elloria Medical Technologies' primary product?

Elloria Medical Technologies' primary product is Electro Chemical Hair Obliteration (ECHO), a permanent hair-removal system that utilizes the company's patented Ellorion technology. This technology is designed to destroy the hair papilla through targeted, noninvasive delivery of negatively charged ions.

What is the key advantage of the ECHO technology?

The ECHO technology, unlike light-based systems, does not rely on pigmentation, making it suitable for all skin and hair colors. It is designed to be fast, continuous, easy to operate, painless, and does not induce adverse side effects or require pre- or post-treatment restrictions.

When was Elloria Medical Technologies founded?

Elloria Medical Technologies was founded in January 2010.

Who is the founder of Elloria Medical Technologies?

Arnon Epstein is the Co-Founder and CEO of Elloria Medical Technologies.

Has Elloria Medical Technologies secured any grants?

In October 2013, Elloria Medical Technologies secured a grant from the Office of the Chief Scientist.